Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03650491
Title A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Fortis Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94143 United States Details
University of Colorado Cancer Center Aurora Colorado 80045 United States Details
Winship Cancer Institute, Emory University Atlanta Georgia 30322 United States Details
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University Baltimore Maryland 21231 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Washington University in St. Louis-Siteman Cancer Center Saint Louis Missouri 63310 United States Details
Icahn School of Medicine at Mt. Sinai New York New York 10029 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field